- Home
- GKOS vs CMC Comparison
GKOS vs CMC Comparison
Compare GKOS & CMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GKOS
- CMC
- Stock Information
- Founded
- GKOS 1998
- CMC 1915
- Country
- GKOS United States
- CMC United States
- Employees
- GKOS N/A
- CMC N/A
- Industry
- GKOS Medical/Dental Instruments
- CMC Steel/Iron Ore
- Sector
- GKOS Health Care
- CMC Industrials
- Exchange
- GKOS Nasdaq
- CMC Nasdaq
- Market Cap
- GKOS 5.1B
- CMC 4.9B
- IPO Year
- GKOS 2015
- CMC 1987
- Fundamental
- Price
- GKOS $89.91
- CMC $46.11
- Analyst Decision
- GKOS Strong Buy
- CMC Buy
- Analyst Count
- GKOS 13
- CMC 7
- Target Price
- GKOS $135.15
- CMC $60.33
- AVG Volume (30 Days)
- GKOS 1.1M
- CMC 805.3K
- Earning Date
- GKOS 04-30-2025
- CMC 06-20-2025
- Dividend Yield
- GKOS N/A
- CMC 1.56%
- EPS Growth
- GKOS N/A
- CMC N/A
- EPS
- GKOS N/A
- CMC 0.63
- Revenue
- GKOS $404,523,000.00
- CMC $7,738,612,000.00
- Revenue This Year
- GKOS $27.84
- CMC N/A
- Revenue Next Year
- GKOS $27.88
- CMC $8.41
- P/E Ratio
- GKOS N/A
- CMC $73.02
- Revenue Growth
- GKOS 23.92
- CMC N/A
- 52 Week Low
- GKOS $77.10
- CMC $37.92
- 52 Week High
- GKOS $163.71
- CMC $64.53
- Technical
- Relative Strength Index (RSI)
- GKOS 45.80
- CMC 57.28
- Support Level
- GKOS $84.26
- CMC $44.67
- Resistance Level
- GKOS $92.27
- CMC $46.61
- Average True Range (ATR)
- GKOS 3.94
- CMC 1.23
- MACD
- GKOS 0.57
- CMC 0.38
- Stochastic Oscillator
- GKOS 58.87
- CMC 83.84
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
About CMC Commercial Metals Company
Commercial Metals Co operates steel mills, steel fabrication plants, and metal recycling facilities in the United States and manufactures rebar and structural steel, which are key product categories for the nonresidential construction sector. The Company has three operating and reportable segments: North America Steel Group, Europe Steel Group and Emerging Businesses Group.